{"id":2815,"date":"2021-11-30T09:52:06","date_gmt":"2021-11-30T08:52:06","guid":{"rendered":"https:\/\/wp.idlbiotech.com\/?page_id=2815"},"modified":"2026-03-02T16:24:47","modified_gmt":"2026-03-02T15:24:47","slug":"financial-presentations","status":"publish","type":"page","link":"https:\/\/idldiagnostics.com\/se\/investors\/financial-reports\/financial-presentations\/","title":{"rendered":"Finansiella presentationer"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;88f366a5-bf49-48d9-a338-ab22706b73e7&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_row column_structure=&#8221;2_3,1_3&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;0px||0px|||&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;2_3&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;||||false|false&#8221; custom_padding_tablet=&#8221;10px||||false|false&#8221; custom_padding_phone=&#8221;0px||||false|false&#8221; custom_padding_last_edited=&#8221;on|phone&#8221; global_colors_info=&#8221;{}&#8221;][dipi_breadcrumbs _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; max_width=&#8221;800px&#8221; global_module=&#8221;5132&#8243; global_colors_info=&#8221;{}&#8221;][\/dipi_breadcrumbs][et_pb_divider color=&#8221;#EEEEEE&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; min_height=&#8221;1px&#8221; height=&#8221;20px&#8221; custom_margin=&#8221;||3px|||&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_divider][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;8738c908-7375-4c6c-99a7-9f91f8a3c099&#8243; header_font_size=&#8221;56px&#8221; custom_margin=&#8221;||17px|||&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h6>Financial presentations<\/h6>\n<h1>Financial presentations<\/h1>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;50px||||false|false&#8221; custom_padding_tablet=&#8221;10px||||false|false&#8221; custom_padding_phone=&#8221;0px||||false|false&#8221; custom_padding_last_edited=&#8221;on|tablet&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;e9afc0e7-c9bf-4a12-be49-63ddba231101&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; width=&#8221;88%&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>IDL Diagnostics (Q4 Interview): Redeye talks with CEO Anders Hultman<\/h3>\n<h5>2026-02-26<\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<div style=\"position:relative; width:100%; aspect-ratio:16\/9;\"><!-- [et_pb_line_break_holder] -->  <iframe src=\"https:\/\/player.vimeo.com\/video\/1168518124?badge=0&amp;autopause=0&amp;player_id=0&amp;app_id=58479\"<!-- [et_pb_line_break_holder] -->    style=&#8221;position:absolute; top:0; left:0; width:100%; height:100%;&#8221; frameborder=&#8221;0&#8243;<!-- [et_pb_line_break_holder] -->    allow=&#8221;autoplay; fullscreen; picture-in-picture; clipboard-write; encrypted-media; web-share&#8221;><!-- [et_pb_line_break_holder] -->  <\/iframe><!-- [et_pb_line_break_holder] --><\/div>\n<p><!-- [et_pb_line_break_holder] --><script src=\"https:\/\/player.vimeo.com\/api\/player.js\"><\/script><!-- [et_pb_line_break_holder] -->[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; width=&#8221;88%&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>IDL Diagnostics: CEO Anders Hultman and CFO Ellen Dittberner present the company\u00b4s Q4 report &#8211; Februari 26, 2026<\/h3>\n<h5>2026-02-26<\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.27.5&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div style=\"position:relative; width:100%; aspect-ratio:16\/9;\"><!-- [et_pb_line_break_holder] -->  <iframe src=\"https:\/\/player.vimeo.com\/video\/1147612241?badge=0&#038;autopause=0&#038;player_id=0&#038;app_id=58479\"<!-- [et_pb_line_break_holder] -->    style=&#8221;position:absolute; top:0; left:0; width:100%; height:100%;&#8221; frameborder=&#8221;0&#8243;<!-- [et_pb_line_break_holder] -->    allow=&#8221;autoplay; fullscreen; picture-in-picture; clipboard-write; encrypted-media; web-share&#8221;><!-- [et_pb_line_break_holder] -->  <\/iframe><!-- [et_pb_line_break_holder] --><\/div>\n<p><!-- [et_pb_line_break_holder] --><script src=\"https:\/\/player.vimeo.com\/api\/player.js\"><\/script><!-- [et_pb_line_break_holder] -->[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; width=&#8221;88%&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>IDL Diagnostics (Q3 Interview): Redeye talks with CEO Anders Hultman<\/h3>\n<h5>2025-11-13<\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div style=\"position:relative; width:100%; aspect-ratio:16\/9;\"><!-- [et_pb_line_break_holder] -->  <iframe src=\"https:\/\/player.vimeo.com\/video\/1136137181?badge=0&#038;autopause=0&#038;player_id=0&#038;app_id=58479\"<!-- [et_pb_line_break_holder] -->    style=&#8221;position:absolute; top:0; left:0; width:100%; height:100%;&#8221; frameborder=&#8221;0&#8243;<!-- [et_pb_line_break_holder] -->    allow=&#8221;autoplay; fullscreen; picture-in-picture; clipboard-write; encrypted-media; web-share&#8221;><!-- [et_pb_line_break_holder] -->  <\/iframe><!-- [et_pb_line_break_holder] --><\/div>\n<p><!-- [et_pb_line_break_holder] --><script src=\"https:\/\/player.vimeo.com\/api\/player.js\"><\/script><!-- [et_pb_line_break_holder] -->[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; width=&#8221;88%&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>IDL Diagnostics: CEO Anders Hultman and CFO Ellen Dittberner present the company\u2019s Q3\u201925 results \u2013 November 12, 2025<\/h3>\n<h5>2025-11-12<\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div style=\"position:relative; width:100%; aspect-ratio:16\/9;\"><!-- [et_pb_line_break_holder] -->  <iframe src=\"https:\/\/player.vimeo.com\/video\/1129111703?badge=0&#038;autopause=0&#038;player_id=0&#038;app_id=58479\"<!-- [et_pb_line_break_holder] -->    style=&#8221;position:absolute; top:0; left:0; width:100%; height:100%;&#8221; frameborder=&#8221;0&#8243;<!-- [et_pb_line_break_holder] -->    allow=&#8221;autoplay; fullscreen; picture-in-picture; clipboard-write; encrypted-media; web-share&#8221;><!-- [et_pb_line_break_holder] -->  <\/iframe><!-- [et_pb_line_break_holder] --><\/div>\n<p><!-- [et_pb_line_break_holder] --><script src=\"https:\/\/player.vimeo.com\/api\/player.js\"><\/script><!-- [et_pb_line_break_holder] -->[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; width=&#8221;88%&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>IDL Diagnostics: Q2\u201925 Interview with CEO Anders Hultman<\/h3>\n<h5>2025-08-22<\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div style=\"position:relative; width:100%; aspect-ratio:16\/9;\"><!-- [et_pb_line_break_holder] -->  <iframe src=\"https:\/\/player.vimeo.com\/video\/1111968330?badge=0&#038;autopause=0&#038;player_id=0&#038;app_id=58479\"<!-- [et_pb_line_break_holder] -->    style=&#8221;position:absolute; top:0; left:0; width:100%; height:100%;&#8221; frameborder=&#8221;0&#8243;<!-- [et_pb_line_break_holder] -->    allow=&#8221;autoplay; fullscreen; picture-in-picture; clipboard-write; encrypted-media; web-share&#8221;><!-- [et_pb_line_break_holder] -->  <\/iframe><!-- [et_pb_line_break_holder] --><\/div>\n<p><!-- [et_pb_line_break_holder] --><script src=\"https:\/\/player.vimeo.com\/api\/player.js\"><\/script><!-- [et_pb_line_break_holder] -->[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; width=&#8221;88%&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>IDL Diagnostics: CEO Anders Hultman och CFO Ellen Dittberner present the company\u00b4s Q2 report \u2013 21 augusti 2025<\/h3>\n<h5>2025-08-21<\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div style=\"position:relative; width:100%; aspect-ratio:16\/9;\"><!-- [et_pb_line_break_holder] -->  <iframe src=\"https:\/\/player.vimeo.com\/video\/1111990418?badge=0&#038;autopause=0&#038;player_id=0&#038;app_id=58479\"<!-- [et_pb_line_break_holder] -->    style=&#8221;position:absolute; top:0; left:0; width:100%; height:100%;&#8221; frameborder=&#8221;0&#8243;<!-- [et_pb_line_break_holder] -->    allow=&#8221;autoplay; fullscreen; picture-in-picture; clipboard-write; encrypted-media; web-share&#8221;><!-- [et_pb_line_break_holder] -->  <\/iframe><!-- [et_pb_line_break_holder] --><\/div>\n<p><!-- [et_pb_line_break_holder] --><script src=\"https:\/\/player.vimeo.com\/api\/player.js\"><\/script><!-- [et_pb_line_break_holder] -->[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; width=&#8221;88%&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>AroCell: Q1\u201925 Interview with CEO Anders Hultman<\/h3>\n<h4>2025-05-12<\/h4>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div style=\"position:relative; width:100%; aspect-ratio:16\/9;\"><!-- [et_pb_line_break_holder] -->  <iframe src=\"https:\/\/player.vimeo.com\/video\/1113565302?badge=0&#038;autopause=0&#038;player_id=0&#038;app_id=58479\"<!-- [et_pb_line_break_holder] -->    style=&#8221;position:absolute; top:0; left:0; width:100%; height:100%;&#8221; frameborder=&#8221;0&#8243;<!-- [et_pb_line_break_holder] -->    allow=&#8221;autoplay; fullscreen; picture-in-picture; clipboard-write; encrypted-media; web-share&#8221;><!-- [et_pb_line_break_holder] -->  <\/iframe><!-- [et_pb_line_break_holder] --><\/div>\n<p><!-- [et_pb_line_break_holder] --><script src=\"https:\/\/player.vimeo.com\/api\/player.js\"><\/script><!-- [et_pb_line_break_holder] -->[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>AroCell: CEO Anders Hultman presents at Redeye Theme Event Medtech \u2013 May 8, 2025<\/h3>\n<h5><span>2025-05-09<\/span><\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div style=\"position:relative; width:100%; aspect-ratio:16\/9;\"><!-- [et_pb_line_break_holder] -->  <iframe src=\"https:\/\/player.vimeo.com\/video\/1113192340?badge=0&#038;autopause=0&#038;player_id=0&#038;app_id=58479\"<!-- [et_pb_line_break_holder] -->    style=&#8221;position:absolute; top:0; left:0; width:100%; height:100%;&#8221; frameborder=&#8221;0&#8243;<!-- [et_pb_line_break_holder] -->    allow=&#8221;autoplay; fullscreen; picture-in-picture; clipboard-write; encrypted-media; web-share&#8221;><!-- [et_pb_line_break_holder] -->  <\/iframe><!-- [et_pb_line_break_holder] --><\/div>\n<p><!-- [et_pb_line_break_holder] --><script src=\"https:\/\/player.vimeo.com\/api\/player.js\"><\/script><!-- [et_pb_line_break_holder] -->[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>AroCell: CEO Anders Hultman and CFO Ellen Dittberner present the company\u2019s Q1\u201925 report \u2013 May 7, 2025<\/h3>\n<h5><span>2025-05-07<\/span><\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div style=\"position:relative; width:100%; aspect-ratio:16\/9;\"><!-- [et_pb_line_break_holder] -->  <iframe src=\"https:\/\/player.vimeo.com\/video\/1113192733?badge=0&#038;autopause=0&#038;player_id=0&#038;app_id=58479\"<!-- [et_pb_line_break_holder] -->    style=&#8221;position:absolute; top:0; left:0; width:100%; height:100%;&#8221; frameborder=&#8221;0&#8243;<!-- [et_pb_line_break_holder] -->    allow=&#8221;autoplay; fullscreen; picture-in-picture; clipboard-write; encrypted-media; web-share&#8221;><!-- [et_pb_line_break_holder] -->  <\/iframe><!-- [et_pb_line_break_holder] --><\/div>\n<p><!-- [et_pb_line_break_holder] --><script src=\"https:\/\/player.vimeo.com\/api\/player.js\"><\/script><!-- [et_pb_line_break_holder] -->[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>AroCell: CEO Anders Hultman presents at Redeye Theme Event: Commercialization in Life Science \u2013 March 20, 2025<\/h3>\n<h5><span>2025-03-21<\/span><\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div style=\"position:relative; width:100%; aspect-ratio:16\/9;\"><!-- [et_pb_line_break_holder] -->  <iframe src=\"https:\/\/player.vimeo.com\/video\/1113197692?badge=0&#038;autopause=0&#038;player_id=0&#038;app_id=58479\"<!-- [et_pb_line_break_holder] -->    style=&#8221;position:absolute; top:0; left:0; width:100%; height:100%;&#8221; frameborder=&#8221;0&#8243;<!-- [et_pb_line_break_holder] -->    allow=&#8221;autoplay; fullscreen; picture-in-picture; clipboard-write; encrypted-media; web-share&#8221;><!-- [et_pb_line_break_holder] -->  <\/iframe><!-- [et_pb_line_break_holder] --><\/div>\n<p><!-- [et_pb_line_break_holder] --><script src=\"https:\/\/player.vimeo.com\/api\/player.js\"><\/script><!-- [et_pb_line_break_holder] -->[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>AroCell: CEO Anders Hultman and CFO Ellen Dittberner present the company\u2019s Q4\u201924 report \u2013 February 19, 2025<\/h3>\n<h5>2025-02-19<\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div style=\"position:relative; width:100%; aspect-ratio:16\/9;\"><!-- [et_pb_line_break_holder] -->  <iframe src=\"https:\/\/player.vimeo.com\/video\/1113200053?badge=0&#038;autopause=0&#038;player_id=0&#038;app_id=58479\"<!-- [et_pb_line_break_holder] -->    style=&#8221;position:absolute; top:0; left:0; width:100%; height:100%;&#8221; frameborder=&#8221;0&#8243;<!-- [et_pb_line_break_holder] -->    allow=&#8221;autoplay; fullscreen; picture-in-picture; clipboard-write; encrypted-media; web-share&#8221;><!-- [et_pb_line_break_holder] -->  <\/iframe><!-- [et_pb_line_break_holder] --><\/div>\n<p><!-- [et_pb_line_break_holder] --><script src=\"https:\/\/player.vimeo.com\/api\/player.js\"><\/script><!-- [et_pb_line_break_holder] -->[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3><span>AroCell: CEO Anders Hultman presents at Redeye Technology &amp; Life Science Day 2024 \u2013 December 3<\/span><\/h3>\n<h5><span>2024-12-05<\/span><\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div style=\"position:relative; width:100%; aspect-ratio:16\/9;\"><!-- [et_pb_line_break_holder] -->  <iframe src=\"https:\/\/player.vimeo.com\/video\/1113201823?badge=0&#038;autopause=0&#038;player_id=0&#038;app_id=58479\"<!-- [et_pb_line_break_holder] -->    style=&#8221;position:absolute; top:0; left:0; width:100%; height:100%;&#8221; frameborder=&#8221;0&#8243;<!-- [et_pb_line_break_holder] -->    allow=&#8221;autoplay; fullscreen; picture-in-picture; clipboard-write; encrypted-media; web-share&#8221;><!-- [et_pb_line_break_holder] -->  <\/iframe><!-- [et_pb_line_break_holder] --><\/div>\n<p><!-- [et_pb_line_break_holder] --><script src=\"https:\/\/player.vimeo.com\/api\/player.js\"><\/script><!-- [et_pb_line_break_holder] -->[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>AroCell: Interview with CEO Anders Hultman<\/h3>\n<h5><span>2024-10-29<\/span><\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div style=\"position:relative; width:100%; aspect-ratio:16\/9;\"><!-- [et_pb_line_break_holder] -->  <iframe src=\"https:\/\/player.vimeo.com\/video\/1113571351?badge=0&#038;autopause=0&#038;player_id=0&#038;app_id=58479\"<!-- [et_pb_line_break_holder] -->    style=&#8221;position:absolute; top:0; left:0; width:100%; height:100%;&#8221; frameborder=&#8221;0&#8243;<!-- [et_pb_line_break_holder] -->    allow=&#8221;autoplay; fullscreen; picture-in-picture; clipboard-write; encrypted-media; web-share&#8221;><!-- [et_pb_line_break_holder] -->  <\/iframe><!-- [et_pb_line_break_holder] --><\/div>\n<p><!-- [et_pb_line_break_holder] --><script src=\"https:\/\/player.vimeo.com\/api\/player.js\"><\/script><!-- [et_pb_line_break_holder] -->[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>AroCell: Interview with CEO Anders Hultman<\/h3>\n<h5>2024-08-23<\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div style=\"position:relative; width:100%; aspect-ratio:16\/9;\"><!-- [et_pb_line_break_holder] -->  <iframe src=\"https:\/\/player.vimeo.com\/video\/1113573619?badge=0&#038;autopause=0&#038;player_id=0&#038;app_id=58479\"<!-- [et_pb_line_break_holder] -->    style=&#8221;position:absolute; top:0; left:0; width:100%; height:100%;&#8221; frameborder=&#8221;0&#8243;<!-- [et_pb_line_break_holder] -->    allow=&#8221;autoplay; fullscreen; picture-in-picture; clipboard-write; encrypted-media; web-share&#8221;><!-- [et_pb_line_break_holder] -->  <\/iframe><!-- [et_pb_line_break_holder] --><\/div>\n<p><!-- [et_pb_line_break_holder] --><script src=\"https:\/\/player.vimeo.com\/api\/player.js\"><\/script><!-- [et_pb_line_break_holder] -->[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>AroCell: Interview with CEO Anders Hultman<\/h3>\n<h5>2024-05-06<\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div style=\"position:relative; width:100%; aspect-ratio:16\/9;\"><!-- [et_pb_line_break_holder] -->  <iframe src=\"https:\/\/player.vimeo.com\/video\/1113578146?badge=0&#038;autopause=0&#038;player_id=0&#038;app_id=58479\"<!-- [et_pb_line_break_holder] -->    style=&#8221;position:absolute; top:0; left:0; width:100%; height:100%;&#8221; frameborder=&#8221;0&#8243;<!-- [et_pb_line_break_holder] -->    allow=&#8221;autoplay; fullscreen; picture-in-picture; clipboard-write; encrypted-media; web-share&#8221;><!-- [et_pb_line_break_holder] -->  <\/iframe><!-- [et_pb_line_break_holder] --><\/div>\n<p><!-- [et_pb_line_break_holder] --><script src=\"https:\/\/player.vimeo.com\/api\/player.js\"><\/script><!-- [et_pb_line_break_holder] -->[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>AroCell: Interview with CEO Anders Hultman<\/h3>\n<h5><span>2024-02-23<\/span><\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div style=\"position:relative; width:100%; aspect-ratio:16\/9;\"><!-- [et_pb_line_break_holder] -->  <iframe src=\"https:\/\/player.vimeo.com\/video\/1113580434?badge=0&#038;autopause=0&#038;player_id=0&#038;app_id=58479\"<!-- [et_pb_line_break_holder] -->    style=&#8221;position:absolute; top:0; left:0; width:100%; height:100%;&#8221; frameborder=&#8221;0&#8243;<!-- [et_pb_line_break_holder] -->    allow=&#8221;autoplay; fullscreen; picture-in-picture; clipboard-write; encrypted-media; web-share&#8221;><!-- [et_pb_line_break_holder] -->  <\/iframe><!-- [et_pb_line_break_holder] --><\/div>\n<p><!-- [et_pb_line_break_holder] --><script src=\"https:\/\/player.vimeo.com\/api\/player.js\"><\/script><!-- [et_pb_line_break_holder] -->[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>AroCell: CEO Anders Hultman &amp; Scientific Advisor Prof. Stig Linder present at Redeye Fight Cancer Event 2024 \u2013 January 24<\/h3>\n<h5><span>2024-01-26<\/span><\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div style=\"position:relative; width:100%; aspect-ratio:16\/9;\"><!-- [et_pb_line_break_holder] -->  <iframe src=\"https:\/\/player.vimeo.com\/video\/1113217265?badge=0&#038;autopause=0&#038;player_id=0&#038;app_id=58479\"<!-- [et_pb_line_break_holder] -->    style=&#8221;position:absolute; top:0; left:0; width:100%; height:100%;&#8221; frameborder=&#8221;0&#8243;<!-- [et_pb_line_break_holder] -->    allow=&#8221;autoplay; fullscreen; picture-in-picture; clipboard-write; encrypted-media; web-share&#8221;><!-- [et_pb_line_break_holder] -->  <\/iframe><!-- [et_pb_line_break_holder] --><\/div>\n<p><!-- [et_pb_line_break_holder] --><script src=\"https:\/\/player.vimeo.com\/api\/player.js\"><\/script>[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>AroCell: Business Update \u2013 29 November, 2023<\/h3>\n<h5><span>2023-11-29<\/span><\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div style=\"position:relative; width:100%; aspect-ratio:16\/9;\"><!-- [et_pb_line_break_holder] -->  <iframe src=\"https:\/\/player.vimeo.com\/video\/1113218342?badge=0&#038;autopause=0&#038;player_id=0&#038;app_id=58479\"<!-- [et_pb_line_break_holder] -->    style=&#8221;position:absolute; top:0; left:0; width:100%; height:100%;&#8221; frameborder=&#8221;0&#8243;<!-- [et_pb_line_break_holder] -->    allow=&#8221;autoplay; fullscreen; picture-in-picture; clipboard-write; encrypted-media; web-share&#8221;><!-- [et_pb_line_break_holder] -->  <\/iframe><!-- [et_pb_line_break_holder] --><\/div>\n<p><!-- [et_pb_line_break_holder] --><script src=\"https:\/\/player.vimeo.com\/api\/player.js\"><\/script><!-- [et_pb_line_break_holder] -->[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>AroCell: Interview with CEO Anders Hultman<\/h3>\n<h5>2023-11-06<\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div style=\"position:relative; width:100%; aspect-ratio:16\/9;\"><!-- [et_pb_line_break_holder] -->  <iframe src=\"https:\/\/player.vimeo.com\/video\/1113804674?badge=0&#038;autopause=0&#038;player_id=0&#038;app_id=58479\"<!-- [et_pb_line_break_holder] -->    style=&#8221;position:absolute; top:0; left:0; width:100%; height:100%;&#8221; frameborder=&#8221;0&#8243;<!-- [et_pb_line_break_holder] -->    allow=&#8221;autoplay; fullscreen; picture-in-picture; clipboard-write; encrypted-media; web-share&#8221;><!-- [et_pb_line_break_holder] -->  <\/iframe><!-- [et_pb_line_break_holder] --><\/div>\n<p><!-- [et_pb_line_break_holder] --><script src=\"https:\/\/player.vimeo.com\/api\/player.js\"><\/script>[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>Arocell: CEO Anders Hultman presents at Redeye Medtech &amp; Diagnostics Event \u2013 26 September 2023<\/h3>\n<h5>2023-09-27<\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div style=\"position:relative; width:100%; aspect-ratio:16\/9;\"><!-- [et_pb_line_break_holder] -->  <iframe src=\"https:\/\/player.vimeo.com\/video\/1113223863?badge=0&#038;autopause=0&#038;player_id=0&#038;app_id=58479\"<!-- [et_pb_line_break_holder] -->    style=&#8221;position:absolute; top:0; left:0; width:100%; height:100%;&#8221; frameborder=&#8221;0&#8243;<!-- [et_pb_line_break_holder] -->    allow=&#8221;autoplay; fullscreen; picture-in-picture; clipboard-write; encrypted-media; web-share&#8221;><!-- [et_pb_line_break_holder] -->  <\/iframe><!-- [et_pb_line_break_holder] --><\/div>\n<p><!-- [et_pb_line_break_holder] --><script src=\"https:\/\/player.vimeo.com\/api\/player.js\"><\/script><!-- [et_pb_line_break_holder] -->[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>AroCell: Video Interview with CEO Anders Hultman<\/h3>\n<h5>2023-08-25<\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div style=\"position:relative; width:100%; aspect-ratio:16\/9;\"><!-- [et_pb_line_break_holder] -->  <iframe src=\"https:\/\/player.vimeo.com\/video\/1113806267?badge=0&#038;autopause=0&#038;player_id=0&#038;app_id=58479\"<!-- [et_pb_line_break_holder] -->    style=&#8221;position:absolute; top:0; left:0; width:100%; height:100%;&#8221; frameborder=&#8221;0&#8243;<!-- [et_pb_line_break_holder] -->    allow=&#8221;autoplay; fullscreen; picture-in-picture; clipboard-write; encrypted-media; web-share&#8221;><!-- [et_pb_line_break_holder] -->  <\/iframe><!-- [et_pb_line_break_holder] --><\/div>\n<p><!-- [et_pb_line_break_holder] --><script src=\"https:\/\/player.vimeo.com\/api\/player.js\"><\/script><!-- [et_pb_line_break_holder] -->[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>AroCell: CEO Anders Hultman presents at Redeye Medtech Event \u2013 May 10, 2023<\/h3>\n<h5>2023-05-11<\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div style=\"position:relative; width:100%; aspect-ratio:16\/9;\"><!-- [et_pb_line_break_holder] -->  <iframe src=\"https:\/\/player.vimeo.com\/video\/1113231081?badge=0&#038;autopause=0&#038;player_id=0&#038;app_id=58479\"<!-- [et_pb_line_break_holder] -->    style=&#8221;position:absolute; top:0; left:0; width:100%; height:100%;&#8221; frameborder=&#8221;0&#8243;<!-- [et_pb_line_break_holder] -->    allow=&#8221;autoplay; fullscreen; picture-in-picture; clipboard-write; encrypted-media; web-share&#8221;><!-- [et_pb_line_break_holder] -->  <\/iframe><!-- [et_pb_line_break_holder] --><\/div>\n<p><!-- [et_pb_line_break_holder] --><script src=\"https:\/\/player.vimeo.com\/api\/player.js\"><\/script><!-- [et_pb_line_break_holder] -->[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>AroCell: Video Interview with CEO Anders Hultman<\/h3>\n<h5>2023-05-08<\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div style=\"position:relative; width:100%; aspect-ratio:16\/9;\"><!-- [et_pb_line_break_holder] -->  <iframe src=\"https:\/\/player.vimeo.com\/video\/1113808565?badge=0&#038;autopause=0&#038;player_id=0&#038;app_id=58479\"<!-- [et_pb_line_break_holder] -->    style=&#8221;position:absolute; top:0; left:0; width:100%; height:100%;&#8221; frameborder=&#8221;0&#8243;<!-- [et_pb_line_break_holder] -->    allow=&#8221;autoplay; fullscreen; picture-in-picture; clipboard-write; encrypted-media; web-share&#8221;><!-- [et_pb_line_break_holder] -->  <\/iframe><!-- [et_pb_line_break_holder] --><\/div>\n<p><!-- [et_pb_line_break_holder] --><script src=\"https:\/\/player.vimeo.com\/api\/player.js\"><\/script><!-- [et_pb_line_break_holder] -->[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>AroCell: Interview with CEO Anders Hultman (video)<\/h3>\n<h5>2023-02-27<\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div style=\"position:relative; width:100%; aspect-ratio:16\/9;\"><!-- [et_pb_line_break_holder] -->  <iframe src=\"https:\/\/player.vimeo.com\/video\/1113809790?badge=0&#038;autopause=0&#038;player_id=0&#038;app_id=58479\"<!-- [et_pb_line_break_holder] -->    style=&#8221;position:absolute; top:0; left:0; width:100%; height:100%;&#8221; frameborder=&#8221;0&#8243;<!-- [et_pb_line_break_holder] -->    allow=&#8221;autoplay; fullscreen; picture-in-picture; clipboard-write; encrypted-media; web-share&#8221;><!-- [et_pb_line_break_holder] -->  <\/iframe><!-- [et_pb_line_break_holder] --><\/div>\n<p><!-- [et_pb_line_break_holder] --><script src=\"https:\/\/player.vimeo.com\/api\/player.js\"><\/script><!-- [et_pb_line_break_holder] -->[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_module=&#8221;3464&#8243; saved_tabs=&#8221;all&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_menu menu_id=&#8221;47&#8243; disabled_on=&#8221;on|on|off&#8221; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#F8F8F8&#8243; global_colors_info=&#8221;{}&#8221;][\/et_pb_menu][et_pb_sidebar area=&#8221;et_pb_widget_area_6&#8243; disabled_on=&#8221;off|off|on&#8221; _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;2efbbc8f-7ecb-4fe3-9956-d83a8a0e7a74&#8243; background_color=&#8221;#F8F8F8&#8243; global_colors_info=&#8221;{}&#8221;][\/et_pb_sidebar][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; disabled_on=&#8221;on|on|on&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;e9afc0e7-c9bf-4a12-be49-63ddba231101&#8243; disabled=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; width=&#8221;88%&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3><span>R<\/span><span>edeye interview with Anders Hultman CEO. Commenting on the Interim Report Q2 2025<\/span><\/h3>\n<p><span>Anders Hultman, CEO, presenting.<\/span><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<iframe allowtransparency=\"true\" title=\"Wistia video player\" allowFullscreen frameborder=\"0\" scrolling=\"no\" class=\"wistia_embed\" name=\"wistia_embed\" src=https:\/\/www.redeye.se\/videoiframe\/1104717 width=\"100%\" height=\"300px\"><\/iframe>[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; width=&#8221;88%&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3><span>Redeye Theme Event: Medtech<\/span><\/h3>\n<h5>2025-05-08<\/h5>\n<p><span>Anders Hultman, CEO, presenting.<\/span><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<iframe allowtransparency=\"true\" title=\"Wistia video player\" allowFullscreen frameborder=\"0\" scrolling=\"no\" class=\"wistia_embed\" name=\"wistia_embed\" src=https:\/\/www.redeye.se\/videoiframe\/1106677 width=\"100%\" height=\"300px\"><\/iframe>[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; width=&#8221;88%&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3><span>Redeye Technology &amp; Life Science Day 2024<\/span><\/h3>\n<h5>2024-12-03<\/h5>\n<p><span>Anders Hultman, CEO, presenting.<\/span><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<iframe loading=\"lazy\" allowtransparency=\"true\" title=\"Wistia video player\" allowFullscreen frameborder=\"0\" scrolling=\"no\" class=\"wistia_embed\" name=\"wistia_embed\" src=\"https:\/\/fast.wistia.net\/embed\/iframe\/phl42h1avi\" width=\"100%\" height=\"300px\"><\/iframe>[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; width=&#8221;88%&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3><span>Redeye Fight Cancer Event 2024<\/span><\/h3>\n<h5>2024-01-24<\/h5>\n<p><span>Anders Hultman, CEO, &amp; Scientific Advisor Prof. Stig Linder presenting.<\/span><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<iframe loading=\"lazy\" allowtransparency=\"true\" title=\"Wistia video player\" allowFullscreen frameborder=\"0\" scrolling=\"no\" class=\"wistia_embed\" name=\"wistia_embed\" src=\"https:\/\/fast.wistia.net\/embed\/iframe\/doh4vkseoy\" width=\"100%\" height=\"300px\"><\/iframe>[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.23.1&#8243; _module_preset=&#8221;default&#8221; width=&#8221;88%&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>AroCell Business Update<\/h3>\n<h4>November 28 2023<\/h4>\n<p>Introduction \u2013 Anders Hultman, CEO<br \/>Financial Position \u2013 Ellen Dittberner, CFO<br \/>Laboratory Tests \u2013 Marie Torstensson, CMO<br \/>Rapid Tests \u2013 Gunnar Wahlberg, CSO<br \/>Clinical Program and Development \u2013 Kiran Jagarlamudi, CScO, and Prof. Stig Linder, Scientific Advisor.<br \/>Q&amp;A with Redeye Equity Analyst \u2013 Oscar Bergman<\/p>\n<p>Watch it here: <a href=\"https:\/\/www.redeye.se\/events\/949216\/business-update-arocell\" title=\"AroCell Business Update\">Link<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/idldiagnostics.com\/wp-content\/uploads\/2023\/11\/Anders-strategy-uppdatering-2023-2.png&#8221; title_text=&#8221;Anders strategy uppdatering 2023 2&#8243; url=&#8221;https:\/\/www.redeye.se\/events\/949216\/business-update-arocell&#8221; align=&#8221;right&#8221; _builder_version=&#8221;4.23.1&#8243; _module_preset=&#8221;default&#8221; max_width=&#8221;85%&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.23.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3><span>R<\/span><span>edeye interview with Anders Hultman CEO. Commenting on the Interim Report Q3 2023<\/span><\/h3>\n<h5><span>2023-11-06<\/span><\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.23.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<iframe loading=\"lazy\" allowtransparency=\"true\" title=\"Wistia video player\" allowFullscreen frameborder=\"0\" scrolling=\"no\" class=\"wistia_embed\" name=\"wistia_embed\" src=\"https:\/\/fast.wistia.net\/embed\/iframe\/ugmsvl8ib3\" width=\"100%\" height=\"300px\"><\/iframe>[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.22.2&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3><span>CEO Anders Hultman presents at Redeye Medtech &amp; Diagnostics Event<\/span><\/h3>\n<h5><span>2023-09-26<\/span><\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.22.2&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<iframe loading=\"lazy\" allowtransparency=\"true\" title=\"Wistia video player\" allowFullscreen frameborder=\"0\" scrolling=\"no\" class=\"wistia_embed\" name=\"wistia_embed\" src=\"https:\/\/fast.wistia.net\/embed\/iframe\/dnyo579fux\" width=\"100%\" height=\"300px\"><\/iframe>[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3><span>R<\/span><span>edeye interview with Anders Hultman CEO. Commenting on the Interim Report Q2 2023<\/span><\/h3>\n<h5><span>2023-08-25<\/span><\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.22.2&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<iframe loading=\"lazy\" allowtransparency=\"true\" title=\"Wistia video player\" allowFullscreen frameborder=\"0\" scrolling=\"no\" class=\"wistia_embed\" name=\"wistia_embed\" src=\"https:\/\/fast.wistia.net\/embed\/iframe\/6ctj3806dl\" width=\"100%\" height=\"300px\"><\/iframe>[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3><span>R<\/span><span>edeye interview with Anders Hultman CEO. Commenting on the Year-end report Q4<\/span><span>\u00a02022<\/span><\/h3>\n<h5><span>2023-02-27<\/span><\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.20.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<iframe loading=\"lazy\" allowtransparency=\"true\" title=\"Wistia video player\" allowFullscreen frameborder=\"0\" scrolling=\"no\" class=\"wistia_embed\" name=\"wistia_embed\" src=\"https:\/\/fast.wistia.net\/embed\/iframe\/8oij1w69f7\" width=\"100%\" height=\"300px\"><\/iframe>[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3><span>Strategy Update Day 2022<\/span><\/h3>\n<h5><span>2022-11-22<\/span><\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<iframe loading=\"lazy\" allowtransparency=\"true\" title=\"Wistia video player\" allowFullscreen frameborder=\"0\" scrolling=\"no\" class=\"wistia_embed\" name=\"wistia_embed\" src=\"https:\/\/fast.wistia.net\/embed\/iframe\/x851u6ggjf\" width=\"100%\" height=\"300px\"><\/iframe>[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3><span>R<\/span><span>edeye interview with Anders Hultman CEO. Commenting on the Interim report Q3 2022<\/span><\/h3>\n<h5><span>2022-10-28<\/span><\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<iframe loading=\"lazy\" allowtransparency=\"true\" title=\"Wistia video player\" allowFullscreen frameborder=\"0\" scrolling=\"no\" class=\"wistia_embed\" name=\"wistia_embed\" src=\"https:\/\/fast.wistia.net\/embed\/iframe\/6grdf5gegl\" width=\"100%\" height=\"300px\"><\/iframe>[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3><span>Anders Hultman CEO presents at Redeye Diagnostics Seminar 2022<\/span><\/h3>\n<h5><span>2022-09-27<\/span><\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<iframe loading=\"lazy\" allowtransparency=\"true\" title=\"Wistia video player\" allowFullscreen frameborder=\"0\" scrolling=\"no\" class=\"wistia_embed\" name=\"wistia_embed\" src=\"https:\/\/fast.wistia.net\/embed\/iframe\/m1tdml9i9f\" width=\"100%\" height=\"300px\"><\/iframe>[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3><span>Redeye interview with Anders Hultman CEO. Commenting on the Interim report Q2 2022<\/span><\/h3>\n<h5><span>2022-08-17<\/span><\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<iframe loading=\"lazy\" allowtransparency=\"true\" title=\"Wistia video player\" allowFullscreen frameborder=\"0\" scrolling=\"no\" class=\"wistia_embed\" name=\"wistia_embed\" src=\"https:\/\/fast.wistia.net\/embed\/iframe\/do6h7c7z7z\" width=\"100%\" height=\"300px\"><\/iframe>[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3><span>Redeye interview with Anders Hultman CEO. Commenting on the Interim report Q1 2022<\/span><\/h3>\n<h5><span>2022-05-03<\/span><\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<iframe loading=\"lazy\" allowtransparency=\"true\" title=\"Wistia video player\" allowFullscreen frameborder=\"0\" scrolling=\"no\" class=\"wistia_embed\" name=\"wistia_embed\" src=\"https:\/\/fast.wistia.net\/embed\/iframe\/nl0uy6fjs8\" width=\"100%\" height=\"300px\"><\/iframe>[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3><span>Redeye interview with Anders Hultman CEO. Commenting on the Interim report Q4 2021<\/span><\/h3>\n<h5><span>2022-03-02<\/span><\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<iframe loading=\"lazy\" allowtransparency=\"true\" title=\"Wistia video player\" allowFullscreen frameborder=\"0\" scrolling=\"no\" class=\"wistia_embed\" name=\"wistia_embed\" src=\"https:\/\/fast.wistia.net\/embed\/iframe\/nox75sol92\" width=\"100%\" height=\"300px\"><\/iframe>[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3><span>Redeye transactions, presenting Anders Hultman CEO.<\/span><\/h3>\n<h5><span>2022-02-03<\/span><\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<iframe loading=\"lazy\" allowtransparency=\"true\" title=\"Wistia video player\" allowFullscreen frameborder=\"0\" scrolling=\"no\" class=\"wistia_embed\" name=\"wistia_embed\" src=\"https:\/\/fast.wistia.net\/embed\/iframe\/0330ot07o3\" width=\"100%\" height=\"300px\"><\/iframe>[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>Redeye interview with AroCell CEO, Anders Hultman. Commenting on the Interim report Q3 2021<\/h3>\n<h5>2021-11-16<\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<iframe loading=\"lazy\" allowtransparency=\"true\" title=\"Wistia video player\" allowFullscreen frameborder=\"0\" scrolling=\"no\" class=\"wistia_embed\" name=\"wistia_embed\" src=\"https:\/\/fast.wistia.net\/embed\/iframe\/3cmbjhwdr1\" width=\"100%\" height=\"300px\"><\/iframe>[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>AroCell&#8217;s CEO, Anders Hultman, commenting the company&#8217;s updated strategy following the merger with IDL Biotech.<\/h3>\n<h5>2021-10-06<\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<iframe loading=\"lazy\" allowtransparency=\"true\" title=\"Wistia video player\" allowFullscreen frameborder=\"0\" scrolling=\"no\" class=\"wistia_embed\" name=\"wistia_embed\" src=\"https:\/\/fast.wistia.net\/embed\/iframe\/gpyuegw2uh\" width=\"100%\" height=\"300px\"><\/iframe>[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>Redeye interview with AroCells CEO, Anders Hultman. Commenting on the Interim report Q2 2021<\/h3>\n<h5>2021-09-02<\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<iframe loading=\"lazy\" allowtransparency=\"true\" title=\"Wistia video player\" allowFullscreen frameborder=\"0\" scrolling=\"no\" class=\"wistia_embed\" name=\"wistia_embed\" src=\"https:\/\/fast.wistia.net\/embed\/iframe\/rk43tw58bw\" width=\"100%\" height=\"300px\"><\/iframe>[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>Interview with Anders Hulman and Peter L\u00f6wendahl.<\/h3>\n<h5>2021-08-12 (In Swedish)<\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<iframe loading=\"lazy\" allowtransparency=\"true\" title=\"Wistia video player\" allowFullscreen frameborder=\"0\" scrolling=\"no\" class=\"wistia_embed\" name=\"wistia_embed\" src=\"https:\/\/fast.wistia.net\/embed\/iframe\/4xvjhecicx\" width=\"100%\" height=\"300px\"><\/iframe>[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>Growth day 2021 &#8211; AroCells CEO Anders Hultman.<\/h3>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<iframe loading=\"lazy\" allowtransparency=\"true\" title=\"Wistia video player\" allowFullscreen frameborder=\"0\" scrolling=\"no\" class=\"wistia_embed\" name=\"wistia_embed\" src=\"https:\/\/fast.wistia.net\/embed\/iframe\/40oz1wp5ai\" width=\"100%\" height=\"300px\"><\/iframe>[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>Redeye intervju with AroCells CEO Anders Hultman.<\/h3>\n<h5>2021-05-19<\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<iframe loading=\"lazy\" allowtransparency=\"true\" title=\"Wistia video player\" allowFullscreen frameborder=\"0\" scrolling=\"no\" class=\"wistia_embed\" name=\"wistia_embed\" src=\"https:\/\/fast.wistia.net\/embed\/iframe\/yvg2wo3qs4\" width=\"100%\" height=\"300px\"><\/iframe>[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>Redeye intervju with AroCells CEO Anders Hultman.<\/h3>\n<h5>2021-05-10<\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<iframe loading=\"lazy\" allowtransparency=\"true\" title=\"Wistia video player\" allowFullscreen frameborder=\"0\" scrolling=\"no\" class=\"wistia_embed\" name=\"wistia_embed\" src=\"https:\/\/fast.wistia.net\/embed\/iframe\/6ffuowhhaw\" width=\"100%\" height=\"300px\"><\/iframe>[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3 class=\"heading\">Investor forum online, Anders Hultman, CEO, presenting.<\/h3>\n<h5>2021-03-04<\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<iframe loading=\"lazy\" allowtransparency=\"true\" title=\"Wistia video player\" allowFullscreen frameborder=\"0\" scrolling=\"no\" class=\"wistia_embed\" name=\"wistia_embed\" src=\"https:\/\/fast.wistia.net\/embed\/iframe\/rphjq0ou60\" width=\"100%\" height=\"300px\"><\/iframe>[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3 class=\"heading\">Redeye interview with AroCell CEO, Anders Hultman. Commenting on the Interim report Q4 2020<\/h3>\n<h5>2021-02-19<\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<iframe loading=\"lazy\" allowtransparency=\"true\" title=\"Wistia video player\" allowFullscreen frameborder=\"0\" scrolling=\"no\" class=\"wistia_embed\" name=\"wistia_embed\" src=\"https:\/\/fast.wistia.net\/embed\/iframe\/dbsw3zojqc\" width=\"100%\" height=\"300px\"><\/iframe>[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3 class=\"heading\">Anders Hultman, CEO, commenting on FDA delay due to covid-19.<\/h3>\n<h5>2021-01-20<\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<iframe loading=\"lazy\" allowtransparency=\"true\" title=\"Wistia video player\" allowFullscreen frameborder=\"0\" scrolling=\"no\" class=\"wistia_embed\" name=\"wistia_embed\" src=\"https:\/\/fast.wistia.net\/embed\/iframe\/7aawuijkxh\" width=\"100%\" height=\"300px\"><\/iframe>[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3 class=\"heading\">Commenting AroCells CEO transition.<\/h3>\n<h5>2021-01-12<\/h5>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<iframe loading=\"lazy\" allowtransparency=\"true\" title=\"Wistia video player\" allowFullscreen frameborder=\"0\" scrolling=\"no\" class=\"wistia_embed\" name=\"wistia_embed\" src=\"https:\/\/fast.wistia.net\/embed\/iframe\/p0d9l6syfq\" width=\"100%\" height=\"300px\"><\/iframe>[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3 class=\"heading\">Life science day 2020<\/h3>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<iframe loading=\"lazy\" allowtransparency=\"true\" title=\"Wistia video player\" allowFullscreen frameborder=\"0\" scrolling=\"no\" class=\"wistia_embed\" name=\"wistia_embed\" src=\"https:\/\/fast.wistia.net\/embed\/iframe\/z8r3iew78f\" width=\"100%\" height=\"300px\"><\/iframe>[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_module=&#8221;3464&#8243; saved_tabs=&#8221;all&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_menu menu_id=&#8221;47&#8243; disabled_on=&#8221;on|on|off&#8221; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#F8F8F8&#8243; global_colors_info=&#8221;{}&#8221;][\/et_pb_menu][et_pb_sidebar area=&#8221;et_pb_widget_area_6&#8243; disabled_on=&#8221;off|off|on&#8221; _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;2efbbc8f-7ecb-4fe3-9956-d83a8a0e7a74&#8243; background_color=&#8221;#F8F8F8&#8243; global_colors_info=&#8221;{}&#8221;][\/et_pb_sidebar][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; custom_padding_last_edited=&#8221;on|tablet&#8221; _builder_version=&#8221;4.9.4&#8243; _module_preset=&#8221;default&#8221; custom_margin_tablet=&#8221;||||false|false&#8221; custom_margin_phone=&#8221;&#8221; custom_margin_last_edited=&#8221;on|tablet&#8221; custom_padding_tablet=&#8221;||0px||false|false&#8221; custom_padding_phone=&#8221;&#8221; global_module=&#8221;2177&#8243; saved_tabs=&#8221;all&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row column_structure=&#8221;1_2,1_2&#8243; make_equal=&#8221;on&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; width=&#8221;90%&#8221; max_width=&#8221;2000px&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#21242A&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h6>About us<\/h6>\n<h3>We provide knowledge to decision.<\/h3>\n<p>IDL Diagnosticsis a Swedish diagnostics company with the vision to improve the monitoring of oncological and bacterial diseases. We have a broad product portfolio of IVD tests that deliver high-value clinical information for the detection of diseases.<\/p>\n<p>[\/et_pb_text][et_pb_button button_url=&#8221;https:\/\/idldiagnostics.com\/about-arocell\/&#8221; button_text=&#8221;Read more about us&#8221; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_button][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/10\/MG_7941-800.jpg&#8221; title_text=&#8221;MG_7941-600&#8243; src_tablet=&#8221;&#8221; src_phone=&#8221;https:\/\/idldiagnostics.com\/wp-content\/uploads\/2023\/08\/MG_7941-600.jpg&#8221; src_last_edited=&#8221;on|phone&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; custom_padding_last_edited=&#8221;on|tablet&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_padding_tablet=&#8221;||0px||false|false&#8221; custom_padding_phone=&#8221;&#8221; global_module=&#8221;2428&#8243; saved_tabs=&#8221;all&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row column_structure=&#8221;1_2,1_2&#8243; make_equal=&#8221;on&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; width=&#8221;90%&#8221; max_width=&#8221;2000px&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; module_class=&#8221;ds-vertical-align&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h6>Bacteriology<\/h6>\n<h3>An effective typhoid test<\/h3>\n<p>Typhoid fever is water and food-borne infectious disease caused by the bacterium, <em>Salmonella<\/em> enterica. IDL Biotechs product TUBEX\u00ae TF, is a rapid and sensitive in vitro diagnostic test for the detection of acute typhoid fever.<\/p>\n<p>[\/et_pb_text][et_pb_button button_url=&#8221;https:\/\/idldiagnostics.com\/products\/bacteriology\/&#8221; button_text=&#8221;Read more about bacteriology&#8221; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;5e8c1032-9074-49bb-92a6-99c20ecc3d02&#8243; global_colors_info=&#8221;{}&#8221;][\/et_pb_button][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/10\/girl-water.jpeg&#8221; title_text=&#8221;Water is Life for African Children, Little Gorgeous Black Girl Drinking from Tap&#8221; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; custom_padding_last_edited=&#8221;on|tablet&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_padding_tablet=&#8221;||0px||false|false&#8221; custom_padding_phone=&#8221;&#8221; global_module=&#8221;2365&#8243; saved_tabs=&#8221;all&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row column_structure=&#8221;1_2,1_2&#8243; make_equal=&#8221;on&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; width=&#8221;90%&#8221; max_width=&#8221;2000px&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; module_class=&#8221;ds-vertical-align&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h6>Oncology<\/h6>\n<h3>Diagnostics for oncology<\/h3>\n<p>Cancer is one of the leading causes of death worldwide, despite advancing knowledge. <span>To improve cancer patient management, there is a clear need for efficient diagnostics tools to capture this critical clinical data.<\/span><\/p>\n<p>[\/et_pb_text][et_pb_button button_url=&#8221;https:\/\/idldiagnostics.com\/products\/oncology\/&#8221; button_text=&#8221;Read more about oncology&#8221; _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;5e8c1032-9074-49bb-92a6-99c20ecc3d02&#8243; global_colors_info=&#8221;{}&#8221;][\/et_pb_button][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/10\/girl-sunset.jpeg&#8221; title_text=&#8221;Happy smiling running beagle dog portrait with tongue out and owner female jogging by the mounting meadow grass path. Walking in nature with pets, happy healthy active people lifestyle concept image.&#8221; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p><div class=\"et_pb_module dipi_breadcrumbs dipi_breadcrumbs_0\">\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t<div class=\"et_pb_module_inner\">\n\t\t\t\t\t<div class=\"dipi-breadcrumbs dipi-bc-left\">\n                <ul >\n                    \n                                                        <li  class=\"dipi-breadcrumb-item dipi-breadcrumb-home\">\n\n                                                    <a  href=\"https:\/\/idldiagnostics.com\/se\">\n                                <span  content=\"Home\">\n                                                                        IDL Diagnostics                                <\/span>\n                            <\/a>\n\n                                                <meta itemprop=\"position\" content=\"1\"\/>                    <\/li>\n\n                    <li class=\"dipi-breadcrumb-separator\">\n                    <span class=\"et-pb-icon dipi-separator-icon\">&#x35;<\/span>\n                <\/li>                            \n                <\/ul>\n            <\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>Financial presentations Financial presentationsIDL Diagnostics (Q4 Interview): Redeye talks with CEO Anders Hultman 2026-02-26IDL Diagnostics: CEO Anders Hultman and CFO Ellen Dittberner present the company\u00b4s Q4 report &#8211; Februari 26, 2026 2026-02-26IDL Diagnostics (Q3 Interview): Redeye talks with CEO Anders Hultman 2025-11-13IDL Diagnostics: CEO Anders Hultman and CFO Ellen Dittberner [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":2257,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"<!-- wp:preformatted -->\n<pre id=\"tw-target-text\" class=\"wp-block-preformatted\"><\/pre>\n<!-- \/wp:preformatted -->\n\n<!-- wp:divi\/placeholder \/-->","_et_gb_content_width":"","footnotes":""},"dipi_cpt_category":[],"class_list":["post-2815","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Financial presentations - IDL Diagnostics<\/title>\n<meta name=\"description\" content=\"Watch our financial presentations here. Redeye interviews, Strategy Updates and more.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/idldiagnostics.com\/se\/investors\/financial-reports\/financial-presentations\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Financial presentations - IDL Diagnostics\" \/>\n<meta property=\"og:description\" content=\"Watch our financial presentations here. Redeye interviews, Strategy Updates and more.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/idldiagnostics.com\/se\/investors\/financial-reports\/financial-presentations\/\" \/>\n<meta property=\"og:site_name\" content=\"IDL Diagnostics\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/arocell\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-02T15:24:47+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/investors\\\/financial-reports\\\/financial-presentations\\\/\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/investors\\\/financial-reports\\\/financial-presentations\\\/\",\"name\":\"Financial presentations - IDL Diagnostics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#website\"},\"datePublished\":\"2021-11-30T08:52:06+00:00\",\"dateModified\":\"2026-03-02T15:24:47+00:00\",\"description\":\"Watch our financial presentations here. Redeye interviews, Strategy Updates and more.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/investors\\\/financial-reports\\\/financial-presentations\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/idldiagnostics.com\\\/investors\\\/financial-reports\\\/financial-presentations\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/investors\\\/financial-reports\\\/financial-presentations\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/idldiagnostics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Investors\",\"item\":\"https:\\\/\\\/idldiagnostics.com\\\/investors\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Financial reports\",\"item\":\"https:\\\/\\\/idldiagnostics.com\\\/investors\\\/financial-reports\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Financial presentations\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#website\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/\",\"name\":\"IDL Diagnostics\",\"description\":\"Saving lives with diagnostics\",\"publisher\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/idldiagnostics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#organization\",\"name\":\"IDL Diagnostics\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/AroCell_logo.png\",\"contentUrl\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/AroCell_logo.png\",\"width\":1713,\"height\":570,\"caption\":\"IDL Diagnostics\"},\"image\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/arocell\",\"https:\\\/\\\/linkedin.com\\\/company\\\/arocell\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Financial presentations - IDL Diagnostics","description":"Watch our financial presentations here. Redeye interviews, Strategy Updates and more.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/idldiagnostics.com\/se\/investors\/financial-reports\/financial-presentations\/","og_locale":"sv_SE","og_type":"article","og_title":"Financial presentations - IDL Diagnostics","og_description":"Watch our financial presentations here. Redeye interviews, Strategy Updates and more.","og_url":"https:\/\/idldiagnostics.com\/se\/investors\/financial-reports\/financial-presentations\/","og_site_name":"IDL Diagnostics","article_publisher":"https:\/\/www.facebook.com\/arocell","article_modified_time":"2026-03-02T15:24:47+00:00","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"5 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/idldiagnostics.com\/investors\/financial-reports\/financial-presentations\/","url":"https:\/\/idldiagnostics.com\/investors\/financial-reports\/financial-presentations\/","name":"Financial presentations - IDL Diagnostics","isPartOf":{"@id":"https:\/\/idldiagnostics.com\/#website"},"datePublished":"2021-11-30T08:52:06+00:00","dateModified":"2026-03-02T15:24:47+00:00","description":"Watch our financial presentations here. Redeye interviews, Strategy Updates and more.","breadcrumb":{"@id":"https:\/\/idldiagnostics.com\/investors\/financial-reports\/financial-presentations\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/idldiagnostics.com\/investors\/financial-reports\/financial-presentations\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/idldiagnostics.com\/investors\/financial-reports\/financial-presentations\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/idldiagnostics.com\/"},{"@type":"ListItem","position":2,"name":"Investors","item":"https:\/\/idldiagnostics.com\/investors\/"},{"@type":"ListItem","position":3,"name":"Financial reports","item":"https:\/\/idldiagnostics.com\/investors\/financial-reports\/"},{"@type":"ListItem","position":4,"name":"Financial presentations"}]},{"@type":"WebSite","@id":"https:\/\/idldiagnostics.com\/#website","url":"https:\/\/idldiagnostics.com\/","name":"IDL Diagnostik","description":"R\u00e4dda liv med diagnostik","publisher":{"@id":"https:\/\/idldiagnostics.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/idldiagnostics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/idldiagnostics.com\/#organization","name":"IDL Diagnostik","url":"https:\/\/idldiagnostics.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/idldiagnostics.com\/#\/schema\/logo\/image\/","url":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/10\/AroCell_logo.png","contentUrl":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/10\/AroCell_logo.png","width":1713,"height":570,"caption":"IDL Diagnostics"},"image":{"@id":"https:\/\/idldiagnostics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/arocell","https:\/\/linkedin.com\/company\/arocell"]}]}},"_links":{"self":[{"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/pages\/2815","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/comments?post=2815"}],"version-history":[{"count":21,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/pages\/2815\/revisions"}],"predecessor-version":[{"id":5458,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/pages\/2815\/revisions\/5458"}],"up":[{"embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/pages\/2257"}],"wp:attachment":[{"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/media?parent=2815"}],"wp:term":[{"taxonomy":"dipi_cpt_category","embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/dipi_cpt_category?post=2815"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}